Recommandations francophones pour le suivi des neurovessies de la sclérose en plaques

Amarenco G, Kerdraon J, Denys P (1995) Les troubles vésicosphinctériens de la sclérose en plaques: étude clinique, urodynamique et neurophysiologique de 225 cas. Rev Neurol 151:722–30

Koldewijn EL, Hommes OR, Lemmens WA, et al (1995) Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 154:169–73

de Sèze M, Ruffion A, Denys P, et al (2006) Les vessies neurologiques et leurs complications dans la sclérose en plaques: revue de la littérature. Pel Perineol 1:77–85

de Sèze M, Ruffion A, Denys P, et al (2007) The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 13:915–28

Gallien P, Robineau S, Nicolas B, et al (1998) Vesicourethral dysfunction and urodynamics findings in multiple sclerosis: a study of 149 cases. Arch Phys Med Rehabil 79:255–7

Giannantoni A, Scivoletto G, Di Stasi SM, et al (1998) Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients. Neurourol Urodyn 17:89–98

de Ridder D, Van Poppel H, Demonty L, et al (1998) Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol 159:1881–4

Lawrenson R, Wyndaele JJ, Vlachonikolis I, et al (2001) Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 187(1–2):138–43

Samellas X, Rubin B (1965) Management of upper urinary tract complications in multiple sclerosis by means of urinary diversion to ileal conduit. J Urol 95:548

Leibowitz U, Kahana E, Jackson SG, et al (1972) The cause of death in multiple sclerosis. In: Progress in multiple sclerosis: research and treatment. Ed Leibowitz U Academic Press New York 196–209

Phadke JG (1987) Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in North east Scotland. J Neurol Neurosurg Psychiatry 50:523–31

Lemack GE, Hawker K, Frohman E (2005) Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation. Urology 65:854–7

Betts C, D’Mellow M, Fowler C (1993) Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 56:245–50

Andrews KL, Husmann DA (1997) Bladder dysfunction and management in multiple sclerosis. Mayo Clin Proc 72:1176–83

Blaivas JG, Bhimani G, Labib KL (1979) Vesicourethral dysfunction in multiple sclerosis. J Urol 122:342–7

Litwiller SE, Frohman M, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 161:743–57

Kragt JJ, Hoogevorst EL, Uitdehaag BM, et al (2004) Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis. Neurology 63:1716–8

Leboeuf L, Gousse AE (2004) Multiple sclerosis. In: Textbook of neurogenic bladder. Adults and children. Corcos J, Schick E Ed Martin Dunitz, London, 275–92

Sirls L, Zimmern P, Leach G (1994) Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 151:946–50

Bonniaud V, Jackowski D, Parratte B, et al (2005) Quality of life in multiple sclerosis patients with urinary disorders: Discriminative validation of the English version of Qualiveen. Qual Life Res 14:425–43